An in vitro cytotoxicity of glufosfamide in HepG2 cells relative to its nonconjugated counterpart.
Autor: | Ahmed DE; Department of Biochemistry, Misr University for Science & Technology (MUST), Giza, Egypt., Rashidi FB; Biochemistry Lab.Department of Chemistry, Faculty of Science, Cairo University, Giza, Egypt. fatmabaiuomy@yahoo.com., Abdelhakim HK; Biochemistry Lab.Department of Chemistry, Faculty of Science, Cairo University, Giza, Egypt., Mohamed AS; Biochemistry Lab.Department of Chemistry, Faculty of Science, Cairo University, Giza, Egypt., Arafa HMM; Department of Pharmacology and Toxicology, Faculty of Pharmacy Ahram Canadian University, Giza, 267119, Egypt. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of the Egyptian National Cancer Institute [J Egypt Natl Canc Inst] 2021 Aug 23; Vol. 33 (1), pp. 22. Date of Electronic Publication: 2021 Aug 23. |
DOI: | 10.1186/s43046-021-00080-6 |
Abstrakt: | Background: Glufosfamide (β-D-glucosylisophosphoramide mustard, GLU) is an alkylating cytotoxic agent in which ifosforamide mustard (IPM) is glycosidically linked to the β-D-glucose molecule. GLU exerted its cytotoxic effect as a targeted chemotherapy. Although, its cytotoxic efficacy in a number of cell lines, there were no experimental or clinical data available on the oncolytic effect of oxazaphosphorine drugs in hepatocellular carcinoma. Therefore, the main objective of the current study is to assess the cytotoxic potential of GLU for the first time in the hepatocellular carcinoma HepG2 cell line model. Methods: Cytotoxicity was assayed by the MTT method, and half-maximal inhibitory concentration (IC Results: Glufosfamide induced cytotoxicity in HepG2 cells in a concentration- and time-dependent manner. The IC Conclusions: The current study reported for the first time cytotoxicity activity of glufosfamide in HepG2 cells in vitro. The obtained results confirmed the higher oncolytic activity of glufosfamide than its aglycone ifosfamide. The generated data warrants further elucidations by in vivo study. (© 2021. The Author(s).) |
Databáze: | MEDLINE |
Externí odkaz: |